Cargando…
Molecular Profiling of Ulcerative Colitis Subjects from the TURANDOT Trial Reveals Novel Pharmacodynamic/Efficacy Biomarkers
BACKGROUND AND AIMS: To define pharmacodynamic and efficacy biomarkers in ulcerative colitis [UC] patients treated with PF-00547659, an anti-human mucosal addressin cell adhesion molecule-1 [MAdCAM-1] monoclonal antibody, in the TURANDOT study. METHODS: Transcriptome, proteome and immunohistochemist...
Autores principales: | Zhou, Huanyu, Xi, Li, Ziemek, Daniel, O’Neil, Shawn, Lee, Julie, Stewart, Zachary, Zhan, Yutian, Zhao, Shanrong, Zhang, Ying, Page, Karen, Huang, Austin, Maciejewski, Mateusz, Zhang, Baohong, Gorelick, Kenneth J, Fitz, Lori, Pradhan, Vivek, Cataldi, Fabio, Vincent, Michael, Von Schack, David, Hung, Kenneth, Hassan-Zahraee, Mina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535501/ https://www.ncbi.nlm.nih.gov/pubmed/30901380 http://dx.doi.org/10.1093/ecco-jcc/jjy217 |
Ejemplares similares
-
Turandot
por: Puccini, Giacomo, 1858-1924
Publicado: (1986) -
Turandot
por: Puccini, Giacomo, 1858-1924
Publicado: (1966) -
Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II
por: Reinisch, Walter, et al.
Publicado: (2021) -
Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn’s Disease
por: Hassan-Zahraee, Mina, et al.
Publicado: (2018) -
Evaluation of two main RNA-seq approaches for gene quantification in clinical RNA sequencing: polyA+ selection versus rRNA depletion
por: Zhao, Shanrong, et al.
Publicado: (2018)